Exclusive: ACR Convergence 2024| Focus Rheums

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

Search results for: stress

Advocacy Is Central to Patient Care, Distinguished Lecturer Says

  |  

When she saw vaping taking hold at a middle school, Kamala Nola, PharmD, MS, spoke up about concerns for the students’ risk of rheumatic disease and other health issues. At ACR Convergence 2022, Dr. Nola emphasized that every healthcare professional can act as an advocate through everyday actions.

Rheum After 5: Finding the Balance

  |  

When he was a boy, Jeff Peterson, MD, fondly remembers that he would help his dad pick blackberries and watch intently as the berries were transformed into wine. “I liked it when my dad offered me a sip because the wine tasted very sweet,” Dr. Peterson says. “It was a special family moment.” These days,…

CORRONA: History & Lessons Learned

Joel M. Kremer, MD, MACR  |  

Editor’s note: In November, the ACR honored Joel M. Kremer, MD, MACR, president of the Corrona Research Foundation, with its Distinguished Clinical Investi­gator Award for his outstanding contributions to the field of rheumatology as a clinical scientist (see story here). As the founder of the Consortium of Rheumatology Researchers of North America (CORRONA, now known…

Highlights from the ACR Review Course 2022

  |  

PHILADELPHIA—At ACR Convergence 2022, the much-anticipated ACR Review Course featured talks from eight experts. Topics reflected the heterogeneity of our field and included Sjögren’s disease, spondyloarthritis (SpA), osteoarthritis (OA), paraneoplastic rheumatic syndromes, metabolic bone disease, statin myopathy, Raynaud’s phenomenon and autoinflammatory syndrome. Here, I share highlights from this comprehensive, six-hour session. Sjögren’s Disease Sara S….

The Secret to Happiness

Philip Seo, MD, MHS  |  

Are you happy? This may be a question born of the pandemic. Pre-pandemic, I used to quote William Osler, MD, who simultaneously founded the Department of Medicine at the Johns Hopkins Hospital and created the modern system of medical education. He opined: The practice of medicine will be very much as you make it—to one,…

Duke Researchers Create a Type 1, Type 2 Lupus Disease Model

Catherine Kolonko  |  

A new disease model for lupus tackles issues with fatigue and other serious conditions that, although quite common among patients, get less attention because they fall outside classic symptoms associated with inflammation, a debilitating force behind systemic lupus erythematosus (SLE). The model features subtypes to cate­gorize two main groups of symptoms into type 1, typically…

New ARP President Kori Dewing, ARNP, DNP, Traces Her Journey to This Point & Possibilities Moving Forward

Leslie Mertz, PhD  |  

Kori Dewing, ARNP, DNP, has been working in healthcare since high school. As she begins her term as president of the ARP, she is building on nearly two decades of volunteer experience with the ARP and ACR to continue supporting rheumatology professionals and advancing the College’s values of inclusion, collaboration and community.

Treat to Target in axSpA

  |  

PHILADELPHIA—Treat to target (T2T) is a common phrase in rheumatology these days—and a welcome one.1 Many of us are familiar with what T2T means in rheumatoid arthritis (RA), but we may be less sure of its meaning in axial spondyloarthritis (axSpA). At ACR Convergence 2022, Alexis Ogdie, MD, associate professor of medicine and epidemiology, University of…